BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28914202)

  • 1. Statins and contrast-induced nephropathy: a systematic review and meta-analysis.
    Briasoulis A; Pala M; Telila T; Merid O; Akintoye E; Vogiatzi G; Oikonomou E; Tousoulis D
    Curr Pharm Des; 2017 Sep; ():. PubMed ID: 28914202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast Induced Nephropathy In High Risk Patients - Myth Or Reality.
    Nabi Z; Anjum N; Rashid RM; Zahideen ZU
    J Ayub Med Coll Abbottabad; 2021; 33(4):568-571. PubMed ID: 35124909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in the prevention of contrast-induced nephropathy.
    Chyou AC; Thodge A; Feldman DN; Swaminathan RV
    Curr Treat Options Cardiovasc Med; 2015 Apr; 17(4):375. PubMed ID: 25778426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
    Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
    Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxy-3-methylglutaryl-CoA reductase enzyme inhibitors for prevention of contrast-induced nephropathy: a meta-analysis of prospective randomized controlled studies.
    Briasoulis A; Mallikethi-Reddy S; Sharma S; Briasouli AA; Afonso L
    Am J Ther; 2015; 22(6):e158-66. PubMed ID: 25187093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Crisci M; Caprile M; Bigazzi MC; Palmieri R; Golia E; De Vita A; Romano IJ; Limongelli G; Russo MG; Calabrò R
    Intern Emerg Med; 2011 Dec; 6(6):503-7. PubMed ID: 21279477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
    Khanal S; Attallah N; Smith DE; Kline-Rogers E; Share D; O'Donnell MJ; Moscucci M
    Am J Med; 2005 Aug; 118(8):843-9. PubMed ID: 16084176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes.
    Zhang MM; Lv QZ; Li XY
    Am J Ther; 2017; 24(4):e423-e430. PubMed ID: 26308327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Contrast-Induced Nephropathy After Cardiovascular Catheterization and Intervention With High-Dose Strong Statin Therapy in Japan - The PREVENT CINC-J Study.
    Watanabe M; Aonuma K; Murohara T; Okumura Y; Morimoto T; Okada S; Nakamura S; Uemura S; Kuwahara K; Takayama T; Doi N; Nakajima T; Horii M; Ishigami K; Nomoto K; Abe D; Oiwa K; Tanaka K; Koyama T; Sato A; Ueda T; Soeda T; Saito Y;
    Circ J; 2022 Aug; 86(9):1455-1463. PubMed ID: 35466156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
    Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
    Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.
    Dvoršak B; Kanič V; Ekart R; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):384-90. PubMed ID: 23931876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of statins in preventing contrast-induced nephropathy: an updated meta-analysis.
    Xie H; Ye Y; Shan G; Zhang S; Fang Q; Yang D; Zeng Y
    Coron Artery Dis; 2014 Nov; 25(7):565-74. PubMed ID: 25036858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of contrast-induced nephropathy in kidney transplant recipients.
    Haider M; Yessayan L; Venkat KK; Goggins M; Patel A; Karthikeyan V
    Transplant Proc; 2015 Mar; 47(2):379-83. PubMed ID: 25769577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of contrast-induced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure.
    Qian G; Liu CF; Guo J; Dong W; Wang J; Chen Y
    Clin Cardiol; 2019 Jan; 42(1):21-25. PubMed ID: 30054906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.